NCT00175253View on ClinicalTrials.gov

Alemtuzumab Induction in Islet Transplantation

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

April 30, 2012

Conditions
Type 1 Diabetes
Interventions
DRUG

alemtuzumab

PROCEDURE

islet transplant

Trial Locations (1)

T6G2C8

University of Alberta - Clinical Islet Transplant Program, Edmonton

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

University of Alberta

OTHER